KIAA1549L

gene
On this page

Also known as G2MGC34830

Summary

KIAA1549L (KIAA1549 like, HGNC:24836) is a protein-coding gene on chromosome 11p13, encoding UPF0606 protein KIAA1549L (Q6ZVL6).

Predicted to be located in membrane.

Source: NCBI Gene 25758 — RefSeq curated summary.

At a glance

  • GWAS associations: 3
  • Clinical variants (ClinVar): 288 total
  • MANE Select transcript: NM_012194

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:24836
Approved symbolKIAA1549L
NameKIAA1549 like
Location11p13
Locus typegene with protein product
StatusApproved
AliasesG2, MGC34830
Ensembl geneENSG00000110427
Ensembl biotypeprotein_coding
OMIM612297
Entrez25758

Gene structure

Transcript identifiers

Ensembl transcripts: 3 — 3 protein_coding

ENST00000265654, ENST00000526400, ENST00000658780

RefSeq mRNA: 2 — MANE Select: NM_012194 NM_001410965, NM_012194

CCDS: CCDS44565, CCDS91457

Canonical transcript exons

ENST00000658780 — 21 exons

ExonStartEnd
ENSE000007101933354476733545378
ENSE000007102083355974933559911
ENSE000007102113356167633561735
ENSE000007102143356807633568227
ENSE000007102163357470233574873
ENSE000008243923354776433547879
ENSE000008243953358333833583501
ENSE000012819913366787333674102
ENSE000015067423366086333661014
ENSE000015067433365875033658898
ENSE000015067453365601233656109
ENSE000015067463364568633646036
ENSE000015067473361853333618662
ENSE000015067493360974933609966
ENSE000015067513360664133606822
ENSE000015067523359882033598947
ENSE000015067543359123733591421
ENSE000015067563355210833552241
ENSE000015067603355104033551259
ENSE000038533033354180233544336
ENSE000038885173337610833376889

Expression profiles

Bgee: expression breadth ubiquitous, 166 present calls, max score 97.25.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 7.3340 / max 445.0339, expressed in 967 samples.

FANTOM5 promoters (10 alternative TSS)

Promoter IDTPM avgSamples expressed
1136764.2778824
1136751.3037564
1136790.5378307
1136740.3738168
1136730.187988
1136800.169686
1136780.158475
1136770.142663
1136810.111651
1136820.070817

Top tissues by expression

273 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
middle temporal gyrusUBERON:000277197.25gold quality
Brodmann (1909) area 23UBERON:001355496.10gold quality
postcentral gyrusUBERON:000258194.75gold quality
superior frontal gyrusUBERON:000266194.47gold quality
endothelial cellCL:000011594.32gold quality
parietal lobeUBERON:000187294.11gold quality
entorhinal cortexUBERON:000272892.81gold quality
cortical plateUBERON:000534390.34gold quality
primary visual cortexUBERON:000243689.84gold quality
prefrontal cortexUBERON:000045188.84gold quality
occipital lobeUBERON:000202188.61gold quality
frontal cortexUBERON:000187087.97gold quality
frontal lobeUBERON:001652587.95gold quality
dorsolateral prefrontal cortexUBERON:000983487.39gold quality
neocortexUBERON:000195086.90gold quality
right frontal lobeUBERON:000281085.96gold quality
cerebral cortexUBERON:000095685.87gold quality
Brodmann (1909) area 9UBERON:001354085.63gold quality
secondary oocyteCL:000065585.11gold quality
ganglionic eminenceUBERON:000402383.22gold quality
telencephalonUBERON:000189382.73gold quality
cingulate cortexUBERON:000302782.19gold quality
anterior cingulate cortexUBERON:000983582.03gold quality
temporal lobeUBERON:000187181.66gold quality
ventricular zoneUBERON:000305381.37gold quality
right hemisphere of cerebellumUBERON:001489081.09gold quality
cerebellar cortexUBERON:000212980.97gold quality
cerebellar hemisphereUBERON:000224580.83gold quality
cerebellumUBERON:000203780.67gold quality
cerebellar vermisUBERON:000472080.51gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 2.

ExperimentMarker?Max mean expression
E-HCAD-25yes79.01
E-ANND-3yes7.39

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

311 targeting KIAA1549L, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-6867-5P100.0082.213464
HSA-MIR-4283100.0066.422097
HSA-MIR-4262100.0073.263931
HSA-MIR-6833-3P100.0070.633197
HSA-MIR-4768-5P100.0069.492861
HSA-MIR-4795-3P100.0074.624024
HSA-MIR-6873-3P100.0071.422626
HSA-MIR-126-5P100.0072.713180
HSA-MIR-7110-3P100.0073.182486
HSA-MIR-4481100.0066.421669
HSA-MIR-5193100.0067.261744
HSA-MIR-656-3P100.0072.152788
HSA-MIR-3646100.0073.565283
HSA-MIR-29A-3P100.0073.111835
HSA-MIR-29B-3P100.0073.181833
HSA-MIR-29C-3P100.0073.151833
HSA-MIR-5196-5P100.0067.982761
HSA-MIR-4673100.0066.641490
HSA-MIR-181A-5P99.9972.962995
HSA-MIR-181B-5P99.9972.972996
HSA-MIR-181C-5P99.9972.952996
HSA-MIR-181D-5P99.9973.042997
HSA-MIR-33A-5P99.9968.621055
HSA-MIR-33B-5P99.9968.581062
HSA-MIR-10401-5P99.9965.79948
HSA-MIR-520D-5P99.9873.344883
HSA-MIR-524-5P99.9873.434882
HSA-MIR-4745-5P99.9865.951028
HSA-MIR-4645-5P99.9865.811284
HSA-MIR-60799.9773.625593

Literature-anchored findings (GeneRIF, showing 1)

  • Four variants in KIAA1549 like (KIAA1549L), a gene previously associated with attempted suicide in bipolar patients, were suggestively associated with being an owl at p < 1.82E-05; post hoc analyses showed the top variant trending in both the Mexican Americans and American Indians cohorts at p = 2.50E-05 and p = .030, respectively (PMID:29192581)

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
danio_reriokiaa1549lbENSDARG00000062086
danio_reriokiaa1549laENSDARG00000062477
mus_musculusD430041D05RikENSMUSG00000068373
rattus_norvegicusD430041D05RiklENSRNOG00000011132

Paralogs (1): KIAA1549 (ENSG00000122778)

Protein

Protein identifiers

UPF0606 protein KIAA1549LQ6ZVL6 (reviewed: Q6ZVL6)

All UniProt accessions (3): A0A590UJI0, A0A5F9UK30, H0YDE5

UniProt curated annotations — full annotation on UniProt →

Subcellular location. Membrane.

Similarity. Belongs to the UPF0606 family.

Isoforms (2)

UniProt IDNamesCanonical?
Q6ZVL6-11yes
Q6ZVL6-22

RefSeq proteins (2): NP_001397894, NP_036326* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR024606KIAA1549Family

Pfam: PF12877

UniProt features (22 total): compositionally biased region 8, region of interest 8, splice variant 3, chain 1, transmembrane region 1, coiled-coil region 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q6ZVL6-F144.780.05

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 137 (showing top): BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN, RIGGI_EWING_SARCOMA_PROGENITOR_UP, TGGAAA_NFAT_Q4_01, MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3, MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3, CYCLIN_D1_UP.V1_UP, KRAS.300_UP.V1_UP, KRAS.50_UP.V1_UP, KRAS.600_UP.V1_UP, KRAS.600.LUNG.BREAST_UP.V1_UP, KRAS.LUNG_UP.V1_UP, KRAS.LUNG.BREAST_UP.V1_UP, KRAS.PROSTATE_UP.V1_UP, MIR153_5P, MIR6867_5P

GO Biological Process (0):

GO Molecular Function (0):

GO Cellular Component (1): membrane (GO:0016020)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure1

Protein interactions and networks

STRING

648 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
KIAA1549LCSTF3Q12996909
KIAA1549LDEPDC7Q96QD5873
KIAA1549LFBXO3Q9UK99872
KIAA1549LCD59P13987650
KIAA1549LLMO2P25791528
KIAA1549LCSTF1Q05048496
KIAA1549LDPRXA6NFQ7467
KIAA1549LHIPK3Q9H422457
KIAA1549LC11orf91Q3C1V1446
KIAA1549LM9MMK7M9MMK7439
KIAA1549LCT83Q5H943396
KIAA1549LMETAP1P53582395
KIAA1549LDNAJC24Q6P3W2377
KIAA1549LCCDC73Q6ZRK6377
KIAA1549LTCP11L1Q9NUJ3375

IntAct

6 interactions, top by confidence:

ABTypeScore
KIAA1549LH2BC21psi-mi:“MI:0915”(physical association)0.400
KIAA1549Lpsi-mi:“MI:0915”(physical association)0.370
KIAA1549LFXR1psi-mi:“MI:0915”(physical association)0.370
GRB2KIAA1549Lpsi-mi:“MI:0915”(physical association)0.000
ATXN1KIAA1549Lpsi-mi:“MI:0915”(physical association)0.000

BioGRID (7): KIAA1549L (Proximity Label-MS), KIAA1549L (Two-hybrid), KIAA1549L (Reconstituted Complex), KIAA1549L (Affinity Capture-MS), KIAA1549L (Affinity Capture-RNA), KIAA1549L (Two-hybrid), KIAA1549L (Two-hybrid)

ESM2 similar proteins: A0A1B0GV85, A1KXC4, A6QLF8, B1ARY8, O14594, O35188, O55145, O60279, O60667, O95196, P07141, P09603, P40225, P40226, P42705, P55066, P55067, P70628, P78423, Q149B8, Q17R60, Q28645, Q2LA85, Q2TB54, Q3TNW5, Q52S86, Q58Y74, Q5IS41, Q5M871, Q5R770, Q5T2D2, Q6PIX9, Q6UXF1, Q6ZVL6, Q7Z434, Q80XH2, Q8BHE4, Q8BT18, Q8C0D9, Q8CAE9

Diamond homologs: Q68FD9, Q6ZVL6, Q9HCM3

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

288 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance254
Likely benign17
Benign4

Top pathogenic / likely-pathogenic (0)

SpliceAI

3327 predictions. Top by Δscore:

VariantEffectΔscore
11:33547762:A:AGacceptor_gain1.0000
11:33547763:G:GGacceptor_gain1.0000
11:33547763:GTT:Gacceptor_gain1.0000
11:33547763:GTTCT:Gacceptor_gain1.0000
11:33547880:G:GGdonor_gain1.0000
11:33552106:A:AGacceptor_gain1.0000
11:33552106:AGT:Aacceptor_gain1.0000
11:33552107:G:GAacceptor_gain1.0000
11:33552107:GT:Gacceptor_gain1.0000
11:33552107:GTG:Gacceptor_gain1.0000
11:33552107:GTGCT:Gacceptor_gain1.0000
11:33552205:G:GTdonor_gain1.0000
11:33552206:A:Tdonor_gain1.0000
11:33552238:TCAGG:Tdonor_loss1.0000
11:33552239:CAGGT:Cdonor_loss1.0000
11:33552240:AGGTA:Adonor_loss1.0000
11:33552241:GGTAG:Gdonor_loss1.0000
11:33552243:T:Gdonor_loss1.0000
11:33559736:T:Aacceptor_gain1.0000
11:33559738:T:TAacceptor_gain1.0000
11:33559741:T:Aacceptor_gain1.0000
11:33559744:TTCAG:Tacceptor_loss1.0000
11:33559745:TCAGA:Tacceptor_loss1.0000
11:33559746:CAG:Cacceptor_loss1.0000
11:33559747:AGA:Aacceptor_loss1.0000
11:33559748:G:GCacceptor_gain1.0000
11:33559748:GA:Gacceptor_gain1.0000
11:33559907:TGAAC:Tdonor_gain1.0000
11:33559908:GAAC:Gdonor_gain1.0000
11:33559908:GAACG:Gdonor_gain1.0000

AlphaMissense

13813 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
11:33574748:T:CL1129P1.000
11:33574786:G:TG1142W1.000
11:33583392:C:AP1189H1.000
11:33583392:C:GP1189R1.000
11:33591249:T:CF1230L1.000
11:33591250:T:GF1230C1.000
11:33591251:T:AF1230L1.000
11:33591251:T:GF1230L1.000
11:33609792:G:CR1405P1.000
11:33609801:T:CL1408P1.000
11:33668081:T:AL1826H1.000
11:33668081:T:CL1826P1.000
11:33668089:G:CA1829P1.000
11:33668093:T:AI1830N1.000
11:33668093:T:CI1830T1.000
11:33668093:T:GI1830S1.000
11:33668096:G:CR1831P1.000
11:33668114:T:CL1837P1.000
11:33552177:T:CL967P0.999
11:33561723:T:AW1059R0.999
11:33561723:T:CW1059R0.999
11:33561725:G:CW1059C0.999
11:33561725:G:TW1059C0.999
11:33568148:T:CL1087P0.999
11:33574753:T:GY1131D0.999
11:33574756:T:GY1132D0.999
11:33574786:G:AG1142R0.999
11:33574786:G:CG1142R0.999
11:33574808:T:CL1149P0.999
11:33583367:T:AW1181R0.999

dbSNP variants (sampled 300 via entrez): RS1000013915 (11:33639186 A>G), RS1000026368 (11:33534985 C>T), RS1000030637 (11:33456473 C>T), RS1000047291 (11:33449882 C>T), RS1000048341 (11:33402744 G>A), RS1000049520 (11:33381433 G>T), RS1000062848 (11:33549187 AT>A), RS1000064645 (11:33418087 T>A), RS1000078956 (11:33402944 T>C), RS1000086675 (11:33528822 G>A), RS1000094279 (11:33593889 T>C,G), RS1000096412 (11:33533766 A>G), RS1000096514 (11:33600547 C>T), RS1000097414 (11:33506560 A>G), RS1000117468 (11:33401688 A>C)

Disease associations

OMIM: gene MIM:612297 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

3 associations (top):

StudyTraitp-value
GCST001015_2Suicide attempts in bipolar disorder4.000000e-06
GCST006585_1604Blood protein levels7.000000e-68
GCST009724_76Vertical cup-disc ratio (multi-trait analysis)2.000000e-09

EFO canonical traits (2, from GWAS)

EFO IDTrait name
EFO:0004321attempted suicide
EFO:0006939cup-to-disc ratio measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

48 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
sodium arsenitedecreases expression, increases abundance, increases expression2
belinostatdecreases expression, affects cotreatment2
Estradiolaffects expression, affects cotreatment, increases expression2
Phenylmercuric Acetateaffects cotreatment, decreases expression2
Valproic Aciddecreases expression2
aristolochic acid Idecreases expression1
FR900359increases phosphorylation1
bisphenol Fdecreases expression, affects cotreatment1
propionaldehydeincreases expression1
bisphenol Adecreases methylation1
trichostatin Aincreases expression1
methylparabendecreases expression1
benzo(e)pyreneincreases methylation1
aflatoxin B2increases methylation1
2-palmitoylglycerolincreases expression1
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamideaffects cotreatment, decreases expression1
abrinedecreases expression1
mirdametinibaffects cotreatment, decreases expression1
dorsomorphindecreases expression, affects cotreatment1
bisphenol Sdecreases methylation1
jinfukangaffects cotreatment, decreases expression1
(+)-JQ1 compoundaffects cotreatment, decreases expression1
Resveratrolaffects cotreatment, decreases expression1
Temozolomidedecreases expression1
Vorinostatdecreases expression1
Arsenicdecreases expression, increases abundance1
Atrazinedecreases expression1
Benzo(a)pyreneincreases methylation1
Cadmiumdecreases expression, increases abundance1
Cisplatinaffects cotreatment, decreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.